Infusion Therapies for Immune Disease
For patients with specific immunological conditions, there are highly specialized programs available at the Mount Sinai AI-FPA.
The AI-FPA staffs the Infusion Therapy Group, where over 100 patients are currently receiving state-of-the-art infusion therapies for a variety of immune disorders. Known as immunomodulation therapy, this treatment approach consists of administering intravenous or subcutaneous immunoglobulin, infliximab, or omalizumab.
5 East 98th Street
New York, NY 10029